By
Associated Press
Published: Sat, April 26, 2008 - 12:51 pm
Last Updated: Sat, April 26, 2008 - 12:56 pm
Last Updated: Sat, April 26, 2008 - 12:56 pm
developed in their labs will successfully suppress advanced breast
cancer in patients for whom all other treatments have failed.
Twenty-five women who are battling terminal breast cancer are
needed to volunteer for a first-of-its-kind FDA-monitored clinical
trial beginning as soon as next month at the Southern Cancer Center
in Mobile.
After more than 30 years of research and development by
scientists at the University of South Alabama College of Medicine,this immunotherapeutic vaccine technology has recently been
approved for testing in humans.
One of the three men who established the new therapy, USA
Department of Microbiology and Immunology Emeritus Professor Joseph
Coggin, says he hopes the trial will lead to broader studies.
Coggin says if it works in Mobile with these 25 women, he's
optimistic the government will let the doctors try this for earlier
cancers at the National Cancer Institutes.
The Southern Cancer Center, Providence Hospital, Mobile
Infirmary, USA's College of Medicine and VRI, Inc., a California
investment group, are partners in the initial clinical study.
(Copyright 2008 by The Associated Press. All Rights Reserved.)
Group Pushes For Birth-Control Patch Ban
News Map
Email to a Friend 
Printer Friendly 
Recently Commented On